613
Views
10
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study

, &
Pages 1130-1134 | Received 25 Mar 2016, Accepted 18 Sep 2016, Published online: 05 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Oren Pasvolsky, Tamar Berger, Karyn Revital Geiger, Amit Akirov, Elias Bshara, Pia Raanani, Anat Gafter-Gvili, Tzippy Shochat, Uri Rozovski & Ronit Gurion. (2022) Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus. Leukemia & Lymphoma 63:14, pages 3378-3384.
Read now
Grace K. Gifford, Andrew J. Gifford, Qian Chen, Yandong Shen, Sara Gabrielli, Anthony J. Gill, William S. Stevenson & Oliver Giles Best. (2020) Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma. Leukemia & Lymphoma 61:8, pages 1810-1822.
Read now

Articles from other publishers (8)

Sarah J. Skuli, Safwan Alomari, Hallie Gaitsch, A’ishah Bakayoko, Nicolas Skuli & Betty M. Tyler. (2022) Metformin and Cancer, an Ambiguanidous Relationship. Pharmaceuticals 15:5, pages 626.
Crossref
Zhen Han, Hong Xu, Meiqing Zhao, Fanjing Jing, Hongwei Xue & Shuxin Xiao. (2022) Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies. Clinical Lymphoma Myeloma and Leukemia 22:2, pages e77-e88.
Crossref
Liam Smyth, Danielle N. Blunt, Evgenia Gatov, Chenthila Nagamuthu, Ruth Croxford, Lee Mozessohn & Matthew C. Cheung. (2020) Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects. British Journal of Haematology 191:3, pages 396-404.
Crossref
Yucai Wang, Matthew J. Maurer, Melissa C. Larson, Cristine Allmer, Andrew L. Feldman, N. Nora Bennani, Carrie A. Thompson, Luis F. Porrata, Thomas M. Habermann, Thomas E. Witzig, Stephen M. Ansell, Susan L. Slager, Grzegorz S. Nowakowski & James R. Cerhan. (2019) Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma. British Journal of Haematology 186:6, pages 820-828.
Crossref
Anne Wynn, Albert Vacheron, Jeffrey Zuber & Solomon S. Solomon. (2019) Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma. The American Journal of the Medical Sciences 358:3, pages 200-203.
Crossref
Jean-Ehrland Ricci & Johanna Chiche. (2018) Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies. Frontiers in Oncology 8.
Crossref
Francesco Ursini, Emilio Russo, Gianluca Pellino, Salvatore D’Angelo, Agostino Chiaravalloti, Giovambattista De Sarro, Roberto Manfredini & Roberto De Giorgio. (2018) Metformin and Autoimmunity: A “New Deal” of an Old Drug. Frontiers in Immunology 9.
Crossref
Mahasweta Gooptu, Diana Whitaker-Menezes, John Sprandio, Marina Domingo-Vidal, Zhao Lin, Guldeep Uppal, Jerald Gong, Roberto Fratamico, Benjamin Leiby, Alina Dulau-Florea, Jaime Caro & Ubaldo Martinez-Outschoorn. (2017) Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma. Seminars in Oncology 44:3, pages 204-217.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.